Search alternatives:
mean decrease » a decrease (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 μ (Expand Search)
5 mg » 5 mm (Expand Search)
Showing 1 - 5 results of 5 for search '(((( 50 n decrease ) OR ( 5 mg decrease ))) OR ( 50 ((ms decrease) OR (mean decrease)) ))~', query time: 0.64s Refine Results
  1. 1
    Effect of different doses (mg/Kg) of the defatted extract (DE) of the leaves of <i>S. malaccense</i> and <i>S. samarangense</i> on serum ALT and AST levels. Data represented as mean±SEM of n = 7, a: significant from the control group at <i>p</i> < 0.001, b: significant from the CdCl<sub>2</sub> group at <i>p</i> < 0.001.

    Effect of different doses (mg/Kg) of the defatted extract (DE) of the leaves of <i>S. malaccense</i> and <i>S. samarangense</i> on serum ALT and AST levels. Data represented as mea... by Fatma A. Moharram (9276104)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Modulation of serum lipid levels after a single-dose treatment of MGL-3196 or T3 in HFD fed rats.

    Modulation of serum lipid levels after a single-dose treatment of MGL-3196 or T3 in HFD fed rats. by Xuan G. Luong (9761423)

    Published 2020
    Save to List
    Saved in:
  3. 3
    Image_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.jpg

    Image_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.jpg by Mario Detomas (11304897)

    Published 2022
    “…This tendency persisted at T2 (-37.3% vs -50.1%; median drug dose: 1250 mg vs 6 mg) while at T3 a decrease in UFC from T0 was more pronounced in the metyrapone group (-71.5% vs -51.5%; median dose 1250 mg vs 7 mg). …”
    Save to List
    Saved in:
  4. 4
    Table_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.docx

    Table_1_Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing’s Syndrome: Results From a Single Center Cohort Study.docx by Mario Detomas (11304897)

    Published 2022
    “…This tendency persisted at T2 (-37.3% vs -50.1%; median drug dose: 1250 mg vs 6 mg) while at T3 a decrease in UFC from T0 was more pronounced in the metyrapone group (-71.5% vs -51.5%; median dose 1250 mg vs 7 mg). …”
    Save to List
    Saved in:
  5. 5
    Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without Diabetes

    Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without Diabetes by Clementine E.M. Verhulst (12889592)

    Published 2022
    “…</p> <p><strong>RESULTS</strong> For the whole group, hypoglycemia decreased the proportion of correct answers on the PASAT by 8.4 ± 12.8%, increased the mean reaction time on the TAP Alertness task by 32.1 ± 66.6 ms, and increased the sum of errors and omissions on the TAP Working Memory task by 2.0 ± 5.5 (all <em>p </em>< 0.001). …”
    Save to List
    Saved in:

Search Tools: